mjbizdaily.com

MJBizDaily publishes daily cannabis industry news on its homepage, organized into Featured stories and a Latest Posts feed. To find the newest coverage, start on the homepage and scan those two sections: Featured highlights the lead stories of the day, while Latest Posts lists recent items in reverse-chronological order with dates. The site covers U.S. and global legal cannabis news, with frequent reporting on regulation, mergers and acquisitions, taxation, and market data.

Where the newest stories appear

The homepage is the fastest entry point. Its structure, as shown on the site, includes:

• Featured — a small set of promoted stories, often the most consequential news of the day.
• Latest Posts — a dated feed of recent articles, each with a headline, a one- or two-sentence summary, and a date (for example, "News October 19").

Scanning Latest Posts top to bottom gives you the most recent items first. The short summaries let you judge relevance before clicking through, which is useful when you only need one topic.

Example of how a day's coverage reads

On a recent homepage snapshot, the lead story covered New York cannabis retailers shrinking orders as payment enforcement tightened, with the summary noting that suppliers must now report unpaid net-30 invoices within seven days. Below it, Latest Posts included:

This pattern shows what to expect: a mix of state-level regulation, federal policy, corporate deals, enforcement actions, and market conditions, updated most weekdays.

Browsing by topic instead of by date

If you are tracking one subject rather than the whole feed, use the headline and summary text to filter. Recurring high-frequency themes on the homepage include:

• Federal rescheduling and its industry impact — for example, coverage of how rescheduling affects tax audits, deal activity, and institutional capital.
• Mergers and acquisitions — bid premiums, board rejections, and takeover negotiations (Curaleaf and Aurora appear repeatedly).
• State regulation and enforcement — payment reporting rules, unlicensed-seller penalties, recall notices, and ballot or repeal fights.
• Tax and legal risk — fraud charges, 280E-related analysis, and compliance opinions such as South Dakota's medical marijuana rules.
• Market access problems — for example, Nebraska growers harvesting crops with no processors, transporters, labs, or dispensaries in place.

Reading the summary line is usually enough to decide whether a story matches your topic; the full article sits behind the headline link.

What to expect from the feed

• Daily cadence: Latest Posts carries dated items, so you can tell how fresh a story is at a glance.
• Sponsored content is labeled: Some items are marked "Sponsored" and sit alongside news, as with a piece on agentic AI for cannabis operators. Treat these as vendor content, not reporting.
• Breadth over depth on the homepage: The homepage gives you headlines and summaries; detailed analysis, data, and legal opinion appear in the linked articles.
• Global scope: The publication describes itself as covering the legal cannabis industry in the U.S. and globally, so expect international items mixed with U.S. state news.

Practical routine for staying current

1. Open the homepage and read the Featured block first — it flags the day's biggest story.
2. Scan Latest Posts for dates and summaries; open only the items matching your topic.
3. For a specific thread (a takeover battle, a state bill, a recall), note the recurring names and dates in the feed and follow the story across consecutive posts.
4. Check back on weekdays; the dated feed shows gaps on quieter days, which tells you when coverage has paused.

If you need one topic rather than everything, the headline-and-summary scan is faster than reading the full feed, and the dates let you confirm you are looking at the most recent development.

MJBizDaily focuses on the business, legal, and regulatory side of the legal cannabis industry rather than consumer or lifestyle content. Based on its current front page, its coverage clusters around four recurring topics: regulation and enforcement, corporate deals and capital, tax and legal risk, and state-level market and product-safety news. If your interest is licensing rules, M&A, tax exposure, or state market shifts, the publication is likely relevant; if you want product reviews or consumer guides, it is not the right fit.

Regulation and enforcement

This is the most frequent category on the page. Recent examples include:

• New York payment enforcement: The state now requires suppliers to report unpaid net-30 invoices within seven days. MJBizDaily frames the retail impact directly—retailers say smaller orders mean lost discounts.
• New Jersey unlicensed sellers: A bipartisan bill would fine unlicensed cannabis retailers $10,000 to $250,000 and shut down repeat offenders.
• Federal rescheduling compliance: A legal opinion suggests states do not need to change their rules to comply with federal marijuana rescheduling, using South Dakota's medical program as the example.

The pattern is consistent: a rule or bill changes, and the coverage explains who it hits and how operators are adjusting.

Corporate deals and capital

MJBizDaily tracks takeover bids and investment shifts as they happen. The Curaleaf–Aurora story is a clear case: Aurora's board rejected Curaleaf's enhanced takeover bid without talks, and Curaleaf pushed back, saying the offer carried a 217% premium when cash is excluded. Aurora also signaled openness to bids from other companies.

Related coverage connects rescheduling to capital flows—one piece argues federal rescheduling means institutional capital is coming to cannabis investing, and another says integration, not just deal volume, decides who wins as rescheduling fuels deals.

Tax and legal risk

Tax exposure gets steady attention, often beyond headline policy:

• 280E and audits: A featured piece looks at hidden tax audit risks of marijuana rescheduling beyond 280E relief.
• Criminal tax charges: The CEO of an Oregon-based vertically integrated multistate operator was charged with federal tax fraud.
• Rescheduling mechanics: Coverage explains how federal rescheduling affects state compliance and deal structures.

State markets and product safety

State-level developments appear daily:

• Massachusetts: The latest poll shows an adult-use sales repeal failing badly—no issue unites voters like keeping sales legal.
• Colorado: A cannabis vape recall expanded as health complaints rose, with three health and safety notices since Sept. 25 pulling Craft THC vapes from more than 700 retailers.
• Nebraska: Medical marijuana growers harvested their first crops with no processors, transporters, labs, or dispensaries to receive them.
• New York market entry: A founder's warning about entering the cannabis industry in 2026—"Don't do it"—reflects the publication's willingness to run skeptical operator voices.

What this means for your reading

One caveat: the page also carries sponsored content, such as a piece on agentic AI for cannabis operators, which is labeled as sponsored and should be read as marketing rather than editorial reporting.

MJBizDaily treats federal marijuana rescheduling as a business and legal story rather than a policy headline, covering it through four recurring lenses: tax exposure, capital flows, M&A activity, and state-level compliance. If you want to understand what rescheduling could change for cannabis operators and investors—and where the risks sit—its coverage clusters around those themes rather than around the rescheduling rule itself.

Tax: Relief and the Audits Behind It

The site's most distinctive angle is that rescheduling is not simply a tax windfall. One featured piece, "Beyond 280E relief: The hidden tax audit risks of marijuana rescheduling," frames the 280E relief question as paired with heightened audit exposure. The takeaway for readers: expect coverage that asks what operators must document and defend, not just what rate they might pay.

Capital: Institutional Money Entering

MJBizDaily connects rescheduling to investment flows directly. A featured headline states that "Federal marijuana rescheduling means institutional capital is coming to cannabis investing," and a companion piece argues that "As rescheduling fuels cannabis deals, integration decides who wins." Read together, the coverage suggests the site's position: rescheduling is a catalyst for deal-making, and post-deal integration—not the regulatory change alone—determines outcomes.

M&A: Live Deal Coverage as a Test Case

The site tracks rescheduling-adjacent consolidation through specific transactions. Its coverage of Curaleaf's pursuit of Aurora Cannabis is a working example: Aurora's board rejected an enhanced takeover bid without talks, while Curaleaf said the offer carried a 217% premium when cash is excluded, and Aurora signaled openness to other bids. Following these stories shows how the site tests the "rescheduling fuels deals" thesis against actual boardroom outcomes.

State Law: Do Rules Need to Change?

On compliance, MJBizDaily published a legal opinion that states don't need to change their rules to comply with federal rescheduling, using South Dakota's existing medical marijuana laws as the example—noting other states may heed the reasoning. This is the site's pattern for state-level questions: report the legal argument and its jurisdictional example rather than issuing blanket guidance.

What Else Sits Alongside Rescheduling Coverage

The homepage mixes rescheduling analysis with operational and enforcement news, which helps set expectations for what you'll find:

How to Use the Coverage

• For tax planning questions, start with the 280E/audit-risk piece and treat it as a prompt to examine your own documentation, not as tax advice.
• For investment theses, pair the institutional-capital article with the integration article; the site's argument depends on execution, not the rescheduling event alone.
• For deal tracking, follow the Curaleaf–Aurora thread as a live case of how bids, premiums, and board rejections actually play out.
• For state compliance, read the South Dakota legal opinion as an argument with a specific jurisdictional basis, and check whether your state's regulator has said anything comparable.

One caveat: the page evidence shows headlines and short excerpts, not full article text. For the underlying legal reasoning or deal terms, open the individual stories rather than relying on the summary lines above.

MJBizDaily is a daily news and data publication focused on the legal cannabis industry in the U.S. and globally. It is aimed at people who need to track the business, financial, legal and regulatory side of cannabis rather than consumer or lifestyle coverage. If you run a cannabis business, invest in the sector, or need to follow how regulation and dealmaking are shifting, it is a relevant source to check regularly; if you want general information about cannabis products or culture, it is not the right fit.

What MJBizDaily covers

The site describes itself as "the most trusted publication covering the legal cannabis industry in the U.S. and globally," with daily industry news and data. Its coverage clusters around a few recurring themes:

• Regulation and enforcement — for example, reporting that New York now requires suppliers to report unpaid net-30 invoices within seven days, and how retailers are responding by shrinking orders.
• M&A and corporate finance — coverage of Curaleaf's takeover bid for Aurora Cannabis, including Aurora's rejection of the enhanced proposal and Curaleaf's response that the offer carried a 217% premium when cash is excluded.
• Tax and legal risk — pieces such as "Beyond 280E relief: The hidden tax audit risks of marijuana rescheduling," and a report that the CEO of an Oregon-based vertically integrated multistate operator was charged with federal tax fraud.
• State-level policy — a poll showing Massachusetts voters broadly oppose repealing adult-use sales, a bipartisan New Jersey bill to fine unlicensed sellers $10,000 to $250,000, and South Dakota's existing medical marijuana laws being judged compliant with federal rescheduling.
• Product safety — an expanding Colorado vape recall tied to rising health complaints, affecting more than 700 retailers.
• Market access gaps — Nebraska medical marijuana growers harvesting their first crops with no processors, transporters, labs or dispensaries to receive them.

How the content is structured

The homepage mixes several formats, which is useful to know before you rely on it:

Dated items (October 14–19 in the sampled page) show the site publishes frequently, so the front page is a reasonable daily check rather than an archive you read once.

Who it is for

The target reader is a professional: cannabis operators, investors, lawyers and compliance staff, and suppliers. Stories are framed around business consequences — lost discounts from smaller orders, who wins when integration follows rescheduling, how institutional capital enters cannabis investing. That framing is the main signal of fit. A founder quoted on entering the industry in 2026 saying "Don't do it" is the kind of operator-facing perspective the publication carries.

Practical caveats

• Sponsored items are labeled but sit alongside news. Read the byline and label before treating a piece as reporting.
• Headlines summarize; details matter. A 217% premium "when cash is excluded" is a specific claim from one party in a bid dispute, not a settled valuation.
• Regulatory stories are state-specific and time-sensitive. The New York invoice-reporting rule and the New Jersey fines bill apply to particular jurisdictions; confirm current status with the relevant state authority before acting.
• It is a news source, not advice. For tax, legal or investment decisions, use the reporting to identify issues and then consult a qualified professional.

For a quick test of fit, open the Latest Posts section and read two or three items in your area — if the business and regulatory angle is what you need, the publication will serve as a useful daily monitor.